I’m trying to get caught up on what I’ve missed over the last few days.
Tonight it’s X22 Report. Listening now to EVERGREEN, Think Depopulation, Panic in DC, James Baker, What a wonderful Day.
The people are now catching on, they see the plan of the [CB]: tax, tax until there is nothing left to give.
This wasn’t this done by the British during the revolutionary war!
The supply chain issue is not going away, Wells Fargo: 6-12 months more of this.
Florida jobs grow at three times the rest of the country.
Panic in DC, James Baker is now being singled out, Durham has questions for him and Sussman. The hunt is on and the people are watching this unfold in real-time.
Everything Trump talked about during his 4 years is now coming true. Don Jr. tweeted out something very interesting, he used [HRC] SS code name Evergreen, was this a message? Think depopulation.
…
Wells Fargo CEO: Supply Chains ‘Will Get Solved’ in ‘6-to-12 Months’
- Wells Fargo CEO and President Charles Scharf, during the annual Milken Institute Global Conference, said he believes that the supply chain crisis will continue roughly “six to 12 months” longer.
- “The realities of things like… wage pressures… supply chain pressures… all these things are going to continue to contribute to this wage inflation that we’re seeing,” Scharf said to Yahoo Finance.
- “That’s all very, very real… all these things will level out. Supply chains will get solved, I personally just think it’s going to be six-to-12 months,” Scharf added when talking about the supermarkets forecasting higher prices.
Q !!mG7VJxZNCI 09/11/2018 19:27:53 ID:
Archive Bread/Post Links: 62 / 221
Direct Link: 221Panic in DC.
James Baker
2323Q !!mG7VJxZNCI 10/03/2018 17:32:38 ID:
Archive Bread/Post Links: 62 / 324
Direct Link: 3242227Q !!mG7VJxZNCI 09/20/2018 13:29:42 ID:
Archive Bread/Post Links: 62 / 267
Direct Link: 267>>221https://www.youtube.com/watch?v=bOwr9PX05p4
[13:35]
Q>>267
Did James Baker just testify behind closed doors [RR] & [JC] coordinated to appoint Mueller?
What a wonderful day.
Q
2369 Q !!mG7VJxZNCI 10/08/2018 13:39:07 ID:
Archive Bread/Post Links: 62 / 363
Direct Link: 363
[Why not?] [if true] D’s do not want DECLAS [TO PROVE] POTUS was colluding w/ RUSSIA?
Why are D’s opposed to DECLAS if what they say is true?
DECLAS would [PROVE] evidence v. POTUS to obtain FISA WARRANT – why the block?
Define ‘Projection’.
See article above – redactions made to ‘protect’ exposing the REAL TRUTH?
Logical thinking.
McCabe Memos [source] >>> NYT [RR] ‘wear a wire’
Sessions Subpoena >>> McCabe Memos delivery to House
Baker Testimony >>> House [what was learned?][D]
[Next Up][RR] Testimony >>> House
Locked & Loaded.
Q
- Black is believed to be the subject of a criminal probe into allegations of rape
- The financier, 70, is accused of raping and sexually abusing two women
- Russian model Guzel Ganieva, 38, filed a lawsuit against Black in June
- The lawsuit was amended in September to include allegations from a Jane Doe
- Black has steadfastly denied the claims that he is a ‘violent and sadistic’ predator
Source: dailymail.co.uk
3856 Q !!Hs1Jq13jV6 02/12/2020
Image Name: D16RNKcWwAAZGaI.jpgFilename: fc76fdb232d23044a10990395268c5610dbcb7005ddcefeb06617699d25b6857.jpThe lines are drawn.
[Zw7301-&vQ-00-00-03]
Define Renegade [Hussein USSS code name].
Standard definition.
Define Evergreen [HRC USSS code name]
Non-standard defintion.
Think depopulation.
The Silent War continues…
Q
Evergreening is achieved by seeking extra patents on variations of the original drug – new forms of release, new dosages, new combinations or variations, or new forms. Big pharma refers to this as “lifecycle management”. Even if the patent is dubious, the company can earn more from the higher prices than it pays in legal fees to keep the dubious patent alive.
Evergreening is possible because in Australia the standard required to get a patent is very low. Different methods of delivering drugs (such as extended release, for example) have been known for decades. But when one of these known delivery methods is combined with a known drug, the patent office considers this sufficiently inventive to grant a new 20-year patent. Another favourite evergreening strategy is to patent a slight variation of the drug.
Brand pharmaceutical companies argue that these “lifecycle management” patents provide improved health outcomes to the community. They meet the (very low) patentability thresholds of novelty and inventiveness. Critics argue that the claimed improved health outcomes are small or non-existent.
